Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H17N3O4 |
InChIKeyQIDVDDJMONJMDF-FQEVSTJZSA-N |
CAS Registry1258494-59-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 22 Feb 2011 |